In this observational cohort of medicare beneficiaries undergoing hip arthroplasty, from 1991 to 2008, the average age increased from 74 to 75, mean co-morbid illnesses increased from 1 to 2, and LOS dramatically dropped from 9.1 to 3.7 days, while 30 day mortality decreased from 0.7% to 0.4% (although 30 day readmission increased from 6% to 8.5%). The percentage of those discharged to home also substantially decreased (from 68% to 48%). Hip arthoplasty patients are older, sicker, stay longer, are less likely to go home, and are more likely to be readmitted. These statistics alone make a very strong argument for surgical-co-management (abstract)
Share This Post
Categories
Related Posts
This article is part of a series in The Hospital Leader written by members of the Division of Hospital Medicine at Dell Medical School at The University of Texas in Austin, exploring lessons learned from the coronavirus pandemic and outlining an approach for creating COVID-19 Centers of Excellence. Patients dying without their loved ones, families […]
Do you have a stack of journals piling up on your desk, beside your bed or in your email inbox? In 1950, medical knowledge was estimated to double every 50 years, but now the doubling time is every few months. At this rate, it is impossible to keep up with the literature, but a group […]
By: Moises Auron, MD, SFHM It is a well-known fact that healthcare expenditure in the United States occupies a large proportion of its gross domestic product, being 17.8% in 2016, which was almost twice to what is expended in other advanced countries; however, this expenditure does not necessarily translate into optimal patient outcomes. In 2012, […]
Leave A Comment